BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29847609)

  • 1. Dendritic potassium channel dysfunction may contribute to dendrite degeneration in spinocerebellar ataxia type 1.
    Chopra R; Bushart DD; Shakkottai VG
    PLoS One; 2018; 13(5):e0198040. PubMed ID: 29847609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal Atrophy Early in Degenerative Ataxia Is a Compensatory Mechanism to Regulate Membrane Excitability.
    Dell'Orco JM; Wasserman AH; Chopra R; Ingram MA; Hu YS; Singh V; Wulff H; Opal P; Orr HT; Shakkottai VG
    J Neurosci; 2015 Aug; 35(32):11292-307. PubMed ID: 26269637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potassium channel dysfunction underlies Purkinje neuron spiking abnormalities in spinocerebellar ataxia type 2.
    Dell'Orco JM; Pulst SM; Shakkottai VG
    Hum Mol Genet; 2017 Oct; 26(20):3935-3945. PubMed ID: 29016852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Novel Activators of Large-Conductance Calcium-Activated Potassium Channels for the Treatment of Cerebellar Ataxia.
    Srinivasan SR; Huang H; Chang WC; Nasburg JA; Nguyen HM; Strassmaier T; Wulff H; Shakkottai VG
    Mol Pharmacol; 2022 Jul; 102(1):438-449. PubMed ID: 35489717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting potassium channels to treat cerebellar ataxia.
    Bushart DD; Chopra R; Singh V; Murphy GG; Wulff H; Shakkottai VG
    Ann Clin Transl Neurol; 2018 Mar; 5(3):297-314. PubMed ID: 29560375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense Oligonucleotide Therapy Targeted Against ATXN3 Improves Potassium Channel-Mediated Purkinje Neuron Dysfunction in Spinocerebellar Ataxia Type 3.
    Bushart DD; Zalon AJ; Zhang H; Morrison LM; Guan Y; Paulson HL; Shakkottai VG; McLoughlin HS
    Cerebellum; 2021 Feb; 20(1):41-53. PubMed ID: 32789747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational analysis of calcium signaling and membrane electrophysiology in cerebellar Purkinje neurons associated with ataxia.
    Brown SA; Loew LM
    BMC Syst Biol; 2012 Jun; 6():70. PubMed ID: 22703638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Capicua expression drives regional Purkinje neuron vulnerability through ion channel gene dysregulation in spinocerebellar ataxia type 1.
    Chopra R; Bushart DD; Cooper JP; Yellajoshyula D; Morrison LM; Huang H; Handler HP; Man LJ; Dansithong W; Scoles DR; Pulst SM; Orr HT; Shakkottai VG
    Hum Mol Genet; 2020 Nov; 29(19):3249-3265. PubMed ID: 32964235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An active membrane model of the cerebellar Purkinje cell. I. Simulation of current clamps in slice.
    De Schutter E; Bower JM
    J Neurophysiol; 1994 Jan; 71(1):375-400. PubMed ID: 7512629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium Signaling, PKC Gamma, IP3R1 and CAR8 Link Spinocerebellar Ataxias and Purkinje Cell Dendritic Development.
    Shimobayashi E; Kapfhammer JP
    Curr Neuropharmacol; 2018 Jan; 16(2):151-159. PubMed ID: 28554312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive impairment of cerebellar mGluR signalling and its therapeutic potential for cerebellar ataxia in spinocerebellar ataxia type 1 model mice.
    Shuvaev AN; Hosoi N; Sato Y; Yanagihara D; Hirai H
    J Physiol; 2017 Jan; 595(1):141-164. PubMed ID: 27440721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ataxic phenotype with altered Ca
    Hashiguchi S; Doi H; Kunii M; Nakamura Y; Shimuta M; Suzuki E; Koyano S; Okubo M; Kishida H; Shiina M; Ogata K; Hirashima F; Inoue Y; Kubota S; Hayashi N; Nakamura H; Takahashi K; Katsumoto A; Tada M; Tanaka K; Sasaoka T; Miyatake S; Miyake N; Saitsu H; Sato N; Ozaki K; Ohta K; Yokota T; Mizusawa H; Mitsui J; Ishiura H; Yoshimura J; Morishita S; Tsuji S; Takeuchi H; Ishikawa K; Matsumoto N; Ishikawa T; Tanaka F
    Neurobiol Dis; 2019 Oct; 130():104516. PubMed ID: 31229688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-ataxic loss of intrinsic plasticity and motor learning in a mouse model of SCA1.
    Osório C; White JJ; Lu H; Beekhof GC; Fiocchi FR; Andriessen CA; Dijkhuizen S; Post L; Schonewille M
    Brain; 2023 Jun; 146(6):2332-2345. PubMed ID: 36352508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C activity is a protective modifier of Purkinje neuron degeneration in cerebellar ataxia.
    Chopra R; Wasserman AH; Pulst SM; De Zeeuw CI; Shakkottai VG
    Hum Mol Genet; 2018 Apr; 27(8):1396-1410. PubMed ID: 29432535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic control of spontaneous bursting in cerebellar Purkinje cells.
    Womack MD; Khodakhah K
    J Neurosci; 2004 Apr; 24(14):3511-21. PubMed ID: 15071098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-symptomatic Delivery of Brain-Derived Neurotrophic Factor (BDNF) Ameliorates Spinocerebellar Ataxia Type 1 (SCA1) Pathogenesis.
    Sheeler C; Rosa JG; Borgenheimer E; Mellesmoen A; Rainwater O; Cvetanovic M
    Cerebellum; 2021 Jun; 20(3):420-429. PubMed ID: 33394333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1.
    Notartomaso S; Zappulla C; Biagioni F; Cannella M; Bucci D; Mascio G; Scarselli P; Fazio F; Weisz F; Lionetto L; Simmaco M; Gradini R; Battaglia G; Signore M; Puliti A; Nicoletti F
    Mol Brain; 2013 Nov; 6():48. PubMed ID: 24252411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Distinct Sets of Ca
    Ait Ouares K; Filipis L; Tzilivaki A; Poirazi P; Canepari M
    J Neurosci; 2019 Mar; 39(11):1969-1981. PubMed ID: 30630881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purkinje cell COX deficiency and mtDNA depletion in an animal model of spinocerebellar ataxia type 1.
    Ripolone M; Lucchini V; Ronchi D; Fagiolari G; Bordoni A; Fortunato F; Mondello S; Bonato S; Meregalli M; Torrente Y; Corti S; Comi GP; Moggio M; Sciacco M
    J Neurosci Res; 2018 Sep; 96(9):1576-1585. PubMed ID: 30113722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term succinic acid treatment mitigates cerebellar mitochondrial OXPHOS dysfunction, neurodegeneration and ataxia in a Purkinje-specific spinocerebellar ataxia type 1 (SCA1) mouse model.
    Ferro A; Carbone E; Zhang J; Marzouk E; Villegas M; Siegel A; Nguyen D; Possidente T; Hartman J; Polley K; Ingram MA; Berry G; Reynolds TH; Possidente B; Frederick K; Ives S; Lagalwar S
    PLoS One; 2017; 12(12):e0188425. PubMed ID: 29211771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.